Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Gossamer Bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +13 vs. Q2 2021
- Shares held
- 54.7M
- +1.66M (+3.1%) vs. Q2 2021
- Total value
- $687.7M
- +$256.7M (+59.5%) vs. Q2 2021
- New holders
- 24
- 35 more added
- Sold out
- 11
- 32 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOSS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $60.8M |
| Q1 2026 | 185 | $56.3M |
| Q4 2025 | 195 | $573.4M |
| Q3 2025 | 164 | $473.7M |
| Q2 2025 | 124 | $218.0M |
| Q1 2025 | 119 | $186.9M |
| Q4 2024 | 105 | $155.0M |
| Q3 2024 | 100 | $172.6M |
| Q2 2024 | 94 | $164.7M |
| Q1 2024 | 109 | $233.5M |
| Q4 2023 | 98 | $192.0M |
| Q3 2023 | 96 | $171.2M |
| Q2 2023 | 99 | $74.4M |
| Q1 2023 | 111 | $97.9M |
| Q4 2022 | 120 | $225.1M |
| Q3 2022 | 160 | $1.02B |
| Q2 2022 | 129 | $533.2M |
| Q1 2022 | 141 | $519.8M |
| Q4 2021 | 133 | $664.9M |
| Q3 2021 | 128 | $687.7M |
| Q2 2021 | 115 | $431.1M |
| Q1 2021 | 123 | $501.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Gossamer Bio, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acuta Capital Partners, LLC | 215,000 | $2.70M | 0.96% | +215,000 | New |
| Bank of New York Mellon Corp | 228,202 | $2.87M | 0.00% | +17,664+8.4% | Added |
| Morgan Stanley | 253,903 | $3.19M | 0.00% | −54,842−17.8% | Reduced |
| Charles Schwab Investment Management Inc | 382,567 | $4.81M | 0.00% | +20,237+5.6% | Added |
| Millennium Management LLC | 508,790 | $6.39M | 0.01% | −98,826−16.3% | Reduced |
| Goldman Sachs Group Inc | 571,917 | $7.19M | 0.00% | +60,342+11.8% | Added |
| Northern Trust Corp | 600,437 | $7.55M | 0.00% | −7,769−1.3% | Reduced |
| Norges Bank | 724,800 | $9.11M | 0.00% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 786,870 | $9.89M | 2.50% | 00.0% | Unchanged |
| Marshall Wace North America L.P. | 840,642 | $10.6M | 0.05% | 00.0% | Unchanged |
| FMR LLC | 894,500 | $11.2M | 0.00% | +894,500 | New |
| Jacobs Levy Equity Management, Inc | 977,363 | $12.3M | 0.08% | −29,116−2.9% | Reduced |
| Geode Capital Management, LLC | 995,761 | $12.5M | 0.00% | +73,467+8.0% | Added |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14.8M | 4.84% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 1,351,933 | $17.0M | 3.89% | +303,550+29.0% | Added |
| Octagon Capital Advisors LP | 1,513,138 | $19.0M | 4.68% | +100,000+7.1% | Added |
| Emerald Advisers, LLC | 1,516,003 | $19.1M | 0.69% | +239,007+18.7% | Added |
| Emerald Mutual Fund Advisers Trust | 1,577,747 | $19.8M | 0.69% | +316,667+25.1% | Added |
| Citadel Advisors LLC | 1,587,951 | $20.0M | 0.02% | +1,572,150+9,949.7% | Added |
| Palo Alto Investors LP | 1,772,950 | $22.3M | 1.35% | 00.0% | Unchanged |
| Artal Group S.A. | 2,358,968 | $29.7M | 0.73% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,462,358 | $31.0M | 1.08% | −100,000−3.9% | Reduced |
| State Street Corp | 2,662,766 | $33.5M | 0.00% | −664,950−20.0% | Reduced |
| Federated Hermes, Inc. | 2,962,234 | $37.2M | 0.07% | +340.0% | Added |
| Omega Fund Management, LLC | 3,320,608 | $41.7M | 4.68% | 00.0% | Unchanged |
| BlackRock Inc. | 5,362,870 | $67.4M | 0.00% | −52,935−1.0% | Reduced |
| Vanguard Group Inc | 5,498,805 | $69.1M | 0.00% | +65,727+1.2% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 7,420,974 | $93.3M | 1.22% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −261,400−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −202,326−100.0% | Sold out |
| Clough Capital Partners L P | 0 | $0 | 0.00% | −159,725−100.0% | Sold out |
| Dowling & Yahnke LLC | 0 | $0 | 0.00% | −95,575−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −13,429−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,271−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,575−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |